Agios Pharmaceuticals Inc... (AGIO)
NASDAQ: AGIO
· Real-Time Price · USD
37.00
0.32 (0.87%)
At close: Aug 15, 2025, 3:59 PM
37.14
0.38%
After-hours: Aug 15, 2025, 07:37 PM EDT
Agios Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 80.87M | 78.96M | 76.25M | 253.73M | 84.52M | 118.76M | 88.2M | 64.33M | 84.75M | 104.14M | 139.26M | 122.45M | 88.54M | 80.03M | 203.13M | 400.22M | 969.12M | 1.89B |
Short-Term Investments | 858.07M | 814.41M | 817.46M | 751.03M | 485.37M | 479.23M | 688.72M | 583.15M | 617.81M | 635.06M | 643.86M | 605.23M | 730.77M | 843.5M | 816.89M | 865.83M | 703.86M | 447.58M |
Long-Term Investments | 400.47M | n/a | 638.32M | 655.89M | 75.4M | 116.3M | 29.43M | 224.9M | 244.36M | 271.73M | 313.87M | 298.35M | 280.85M | 255.84M | 266.38M | 130.14M | 61.31M | 21.6M |
Other Long-Term Assets | 3.94M | 535.97M | 4.72M | 4.06M | 4.06M | 4.06M | 4.06M | 4.06M | 4.06M | 3.96M | 3.96M | 3.9M | 3.96M | 2.9M | 2.9M | 2.9M | 2.9M | n/a |
Receivables | 4.99M | 3.34M | 4.11M | 3.12M | 3.76M | 3.45M | 2.81M | 1.18M | 2.25M | 1.78M | 2.21M | 5.59M | 4.3M | 5.91M | 4.38M | 6.99M | 8.13M | n/a |
Inventory | 30.85M | 29.61M | 27.62M | 26.43M | 23.94M | 23.07M | 19.08M | 17.27M | 15.67M | 11.37M | 8.49M | 5.18M | 4.06M | 2.48M | 16.19M | n/a | n/a | n/a |
Other Current Assets | 44.69M | 42.29M | 40.16M | 39.88M | 34.54M | 39.11M | 35.02M | 38.41M | 36.75M | 39.3M | 38.95M | n/a | n/a | n/a | n/a | n/a | n/a | 19.51M |
Total Current Assets | 1.02B | 968.62M | 965.6M | 1.07B | 632.13M | 663.63M | 833.84M | 704.35M | 757.24M | 791.66M | 832.77M | 784.93M | 870.01M | 975.14M | 1.06B | 1.31B | 1.7B | 2.36B |
Property-Plant & Equipment | 47.36M | 50.93M | 54.55M | 57.66M | 61.48M | 65.72M | 69.79M | 73.95M | 79.5M | 83.96M | 88.12M | 93.13M | 97.66M | 101.98M | 104.23M | 103.17M | 107.83M | 111.72M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 451.77M | 586.9M | 697.6M | 717.61M | 140.94M | 186.08M | 103.28M | 302.91M | 327.91M | 359.64M | 405.95M | 395.38M | 382.46M | 360.71M | 373.5M | 236.21M | 172.04M | 133.32M |
Total Assets | 1.47B | 1.56B | 1.66B | 1.79B | 773.06M | 849.71M | 937.12M | 1.01B | 1.09B | 1.15B | 1.24B | 1.18B | 1.25B | 1.34B | 1.44B | 1.54B | 1.87B | 2.49B |
Account Payables | 17.53M | 13.73M | 16.64M | 17.14M | 10.04M | 11.15M | 9.78M | 13.27M | 11.63M | 8.66M | 18.62M | 10.41M | 7.79M | 11.55M | 16.7M | 10.31M | 7.65M | 51.22M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.22M | 2.5M | n/a | n/a | n/a | n/a |
Short-Term Debt | 17.59M | 17.2M | n/a | n/a | 15.86M | n/a | 15.01M | 14.66M | 14.33M | 13.99M | n/a | 13.43M | 12.22M | 11.99M | n/a | 10.29M | 9.77M | n/a |
Other Current Liabilities | 19.97M | 21.44M | 63.64M | 15.62M | 8.92M | 19.73M | 8.22M | 1.8M | 3.98M | 1.82M | 12.24M | 2.32M | 2.95M | 2.37M | 12.15M | 5.34M | 15.72M | 16.25M |
Total Current Liabilities | 70.41M | 52.37M | 81.16M | 119.45M | 62.64M | 51.69M | 67.95M | 58.42M | 55.14M | 45.11M | 62.63M | 53.6M | 48.4M | 45.79M | 59.83M | 57.9M | 60.65M | 96.5M |
Long-Term Debt | 31.17M | 35.74M | n/a | n/a | 48.76M | n/a | 56.99M | 60.83M | 64.62M | 68.35M | n/a | n/a | n/a | 82.61M | n/a | 88.84M | 92.14M | 95.3M |
Other Long-Term Liabilities | 101K | 880K | 880K | 1.16M | -47.6M | 1.16M | -55.83M | -59.68M | -63.46M | -67.03M | 3.28M | 1.05M | 1.05M | -82.61M | n/a | -88.84M | -92.14M | -95.3M |
Total Long-Term Liabilities | 31.27M | 36.62M | 41.09M | 45.67M | 49.92M | 54.1M | 58.14M | 61.99M | 65.78M | 69.66M | 75.28M | 76.55M | 80M | 82.61M | 85.94M | 88.84M | 92.14M | 95.3M |
Total Liabilities | 101.68M | 88.99M | 122.24M | 165.12M | 112.55M | 105.79M | 126.1M | 120.42M | 120.92M | 114.77M | 137.9M | 130.15M | 128.4M | 128.41M | 145.76M | 146.74M | 152.79M | 191.8M |
Total Debt | 48.76M | 52.94M | 56.99M | 60.83M | 64.62M | 68.35M | 72M | 75.5M | 78.95M | 82.34M | 85.66M | 88.92M | 91.17M | 94.61M | 97.09M | 99.14M | 101.91M | 103.61M |
Common Stock | 74K | 74K | 73K | 73K | 73K | 73K | 72K | 72K | 72K | 72K | 71K | 71K | 71K | 71K | 71K | 71K | 70K | 70K |
Retained Earnings | -350.23M | -238.21M | -148.92M | -52.4M | -1B | -904.2M | -822.65M | -726.71M | -635.38M | -551.58M | -470.56M | -507.09M | -425.34M | -333.53M | -238.76M | -144.13M | -55.37M | 30.85M |
Comprehensive Income | 655K | 365K | -1.52M | 3.42M | -1.04M | -1.09M | -441K | -5.9M | -8.87M | -8.41M | -12.54M | -15.08M | -10.5M | -7.75M | -1.2M | -198K | -144K | -3K |
Shareholders Equity | 1.37B | 1.47B | 1.54B | 1.63B | 660.51M | 743.92M | 811.02M | 886.84M | 964.24M | 1.04B | 1.1B | 1.05B | 1.12B | 1.21B | 1.29B | 1.39B | 1.72B | 2.3B |
Total Investments | 1.26B | 814.41M | 1.46B | 1.41B | 560.78M | 595.53M | 718.16M | 583.15M | 617.81M | 635.06M | 957.73M | 903.58M | 1.01B | 1.1B | 1.08B | 995.97M | 765.18M | 469.18M |